Nitric oxide signaling in the ischemic postconditioning of human heart muscle (RCD code: III)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 2, Issue 6
Abstract
Background: Ischemic heart conditioning is well documented to trigger the intrinsic protective mechanisms of resistance against ischemia/reperfusion (I/R) injury. Previous studies on animal model have suggested that the nitric oxide (NO) mediates the beneficial effect of ischemic postconditioning (POC). We tested the hypothesis that POC provide cardioprotection in the NO-dependent mechanism in the human myocardium. Methods: Human atrial trabeculae were subjected to simulated I/R injury. To achieve POC triple brief hypoxia periods were followed by the lethal hypoxia. Non-selective inhibitor of NO synthase: NG-monomethyl-L-arginine (L-NMMA) was used at the time of re-oxygenation in the POC protocol. Contractility of the myocardium was assessed as the maximal force of a contraction (Amax), the rate of rise of the force of a contraction (Slope L) and cardiac muscle relaxation – as the rate of decay of the force of a contraction (Slope T). Results: Co-application of L-NMMA with POC resulted in the decrease of Amax, Slope L and Slope T during re-oxygenation period as compared to POC only. Conclusions: At re-oxygenation period, the blockade of NO synthesis has deleterious effect on systolic and diastolic function of human myocardium, as well as attenuates the beneficial effect of ischemic.
Authors and Affiliations
Marcin Kunecki, Wojciech Płazak, Piotr Podolec, Tomasz Roleder, Jolanta Biernat, Marek Deja, Krzysztof Gołba
Keywords
Related Articles
- EP ID EP248094
- DOI 10.20418/jrcd.vol2no6.228
- Views 86
- Downloads 0
Highlights from EuroEcho-Imaging 2016 Congress of the European Society of Cardiology, Leipzig, Germany.
EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), that attracts participants from all over the world with all modalities of cardiovascular non-invasive imaging. This ti...
The 4th Conference of Working Group in Congenital Heart Diseases of Polish Society of Cardiology
Congenital heart disease (CHD) is the most common developmental anomaly and represents about 1% of all live-born children. Recent progress in cardiac surgery and pediatric cardiology has resulted in large numbers of adu...
1st International Conference on Rare Cardiovascular Diseases (Krakow, October 18–19, 2012)
Doctors, like other academic professionals, know very well that there is no better place than a live conference to share knowledge and experience or to interact with people of similar interests.Encouraged by the success...
Journal of Rare Cardiovascular Diseases: Moving towards maturity, and implementing the Krakow RCD Classification as a milestone
Dear Readers – our Friends and Colleagues,The present, third, issues of your quarterly Journal of Rare Cardiovascular Diseases is an important landmark in the life of the Journal; the life that presents a process from in...
2nd Symposium on Rare Cardiovascular Diseases – ESC Munich 2012: Chairperson’s Perspective
In response to interest generated by the 1st Satellite Symposium on Rare Cardiovascular Diseases (Paris, ESC 2011), a session devoted to managing patients with rare cardiovascular diseases was organized this year again,...